VGXI Blog & News

Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.

Future Proof Your Advanced Therapies Supply Chain with VGXI’s US-Based Plasmid CDMO Expertise

In the current landscape of biopharmaceutical drug development, finding a reliable and experienced contract development and manufacturing organization (CDMO) partner is a strategic advantage that can greatly influence the success of an advanced therapeutic program. Whether you are developing[…]

  Read More

VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline

VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]

  Read More

VGXI’s Expanded Manufacturing Capacity Addresses Plasmid DNA Supply Chain Challenges

Plasmid DNA (pDNA) is an essential part of the supply chain for advanced therapies and[…]

  Read More

Five Qualities to Look for in a CDMO

As the biopharmaceutical industry increasingly turns to outsourcing, the key to success lies in[…]

  Read More

Stephanie Burke Named as VGXI’s New Chief Accounting Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]

  Read More

VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization

Plasmids are small, circular, double-stranded DNA molecules that have become indispensable[…]

  Read More

VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer

Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]

  Read More

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]

  Read More

An Introduction to DNA and Vaccines

Vaccines are one of humanity’s most important inventions as they help protect public health[…]

  Read More

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening[…]

  Read More